BioMarin Announces Program for ERT for Treatment of MPS IVA

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Reply to topic
BioMarin Announces Program for ERT for Treatment of MPS IVA
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Reply with quote


BioMarin Pharmaceutical Inc. today announced its program for its third enzyme replacement therapy for the treatment of mucopolysaccharidosis IVA , or Morquio A Syndrome.

Read more...
View user's profileSend private message
BioMarin Announces Program for ERT for Treatment of MPS IVA
All times are GMT - 7 Hours  
Page 1 of 1  

  
  
 Reply to topic  
Forum Map
Site Map